Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ER positive + FGFR1 amplification
i
Other names:
ESR1, Era, ESR, NR3A1, ER, ER beta, FGFR1, BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM, Fibroblast growth factor receptor 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2099
;
2260
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
FGFR1 fusion (6)
ZMYM2-FGFR1 fusion (5)
ER-CCDC170 fusion (3)
FGFR1OP2-FGFR1 fusion (3)
BCR-FGFR1 fusion (2)
BAG4-FGFR1 B2F6 (1)
FGFR1-G3BP2 fusion (1)
FGFR1-PLAG1 fusion (1)
FGFR1-TACC1 fusion (1)
FGFR1 fusion (6)
ZMYM2-FGFR1 fusion (5)
ER-CCDC170 fusion (3)
FGFR1OP2-FGFR1 fusion (3)
BCR-FGFR1 fusion (2)
BAG4-FGFR1 B2F6 (1)
FGFR1-G3BP2 fusion (1)
FGFR1-PLAG1 fusion (1)
FGFR1-TACC1 fusion (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ER positive + FGFR1 amplification
HER2 Negative Breast Cancer
ER positive + FGFR1 amplification
HER2 Negative Breast Cancer
palbociclib + erdafitinib
Sensitive: C3 – Early Trials
palbociclib + erdafitinib
Sensitive
:
C3
palbociclib + erdafitinib
Sensitive: C3 – Early Trials
palbociclib + erdafitinib
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login